---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-21-021753"
form_type: "8-K"
ticker: "PRCT"
cik: "0001588978"
company_name: "PROCEPT BioRobotics Corp"
filed_at: "2021-11-04T23:59:59+00:00"
generated_at: "2026-06-28T12:59:56.264342+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# PROCEPT Q3 revenue $8.7M up 314% YoY; raises FY 2021 guide to $33.0-$33.3M

## Summary
- Total revenue of $8.7M vs. $2.1M in Q3 2020; U.S. system revenue $5.0M vs. $0.6M.
- Net loss of $14.1M; cash and short-term investments $320.5M after $172.4M IPO net proceeds.
- Gross margin 48.9%, up from -1% in Q3 2020 and 42.2% in Q2 2021.
- Full-year 2021 revenue guidance raised to $33.0-$33.3M.
- Cigna adopted positive coverage policy for Aquablation, adding 16M covered lives effective Sept 15, 2021.

## SEC filing metadata
- accession: 0001628280-21-021753
- form_type: 8-K
- ticker: PRCT
- cik: 0001588978
- company_name: PROCEPT BioRobotics Corp
- filed_at: 2021-11-04T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1588978/000162828021021753/0001628280-21-021753-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1588978/000162828021021753/prct-20211104.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-21-021753
- JSON: https://secwatch.observer/filing/0001628280-21-021753.json
- Plain text: https://secwatch.observer/filing/0001628280-21-021753.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.